Non-synonymous genetic variation in exonic regions of canine Toll-like receptors by Cuscó, Anna et al.
Cuscó et al. Canine Genetics and Epidemiology 2014, 1:11
http://www.cgejournal.org/content/1/1/11RESEARCH Open AccessNon-synonymous genetic variation in exonic
regions of canine Toll-like receptors
Anna Cuscó1,2, Armand Sánchez1, Laura Altet2, Lluís Ferrer3 and Olga Francino1*Abstract
Background: Toll-like receptors (TLRs) are pattern recognition receptors (PRRs) considered to be the primary
sensors of pathogens in innate immunity. Genetic variants could be associated to differences in breed innate
immune response to pathogens and thus to susceptibility to infections or autoimmune diseases. There is therefore
great interest in the characterization of canine TLRs.
Results: Polymorphisms in canine TLRs have been characterized by massive sequencing after enrichment of their
exonic regions. DNAs from 335 dogs (seven different breeds) and 100 wolves (two different populations) were used
in pools. The ratio of SNP discovery was 76.5% (in relation to CanFam 3.1); 155 out of 204 variants identified were
new. Functional annotation identified 64 non-synonymous variants (43 new), 73 synonymous variants (56 new) and
67 modifier variants (57 new). 12 out of 64 non-synonymous variants are breed or wolf specific. TLR5 has been
found to be the most polymorphic among canine TLRs. Finally, a TaqMan OpenArray® plate containing 64 SNPs
with a possible functional effect in the protein (4 frameshifts and 60 non-synonymous codons) has been designed
and validated.
Conclusions: Non-synonymous genetic variation has been characterized in exonic regions of canine Toll-like Receptors.
The TaqMan OpenArray® plate developed to capture the individual variability that affects protein function will allow
high-throughput genotyping either to study association to infection susceptibility or even TLR evolution in the canine
genome.
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Toll-like receptors (TLRs) are pattern recognition recep-
tors (PRRs) and are the primary sensors of pathogens in
the body. Genetic variants could be associated with differ-
ences in breed response to pathogens and also to suscepti-
bility to infections and/or autoimmune diseases. There is
great interest in the characterization of canine TLRs.
Genetic variation in canine TLRs has been characterized
using massive parallel sequencing. DNA from 335 dogs
(seven breeds: Beagle, German Shepherd dog, Yorkshire
terrier, French bulldog, Boxer, Labrador and Shar Pei) plus
100 wolves (two populations: Iberian and Russian) were
sequenced in 16 pools of 25 dogs or 50 wolves. In total,
we found 204 variants, of which 155 were new. Compa-
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unless otherwise stated.sequence (called CanFam 3.1) Functional annotation iden-
tified 64 non-synonymous variants (43 new), 73 synonym-
ous variants (56 new) and 67 modifier variants (57 new).
Twelve of 64 non-synonymous variants were breed or wolf
specific. TLR5 has been found to be the most polymorphic
among canine TLRs. Finally, a TaqMan OpenArray(R)
plate containing 64 SNPs with a possible functional effect
in the protein (4 frameshifts and 60 non-synonymous
codons) has been designed and validated.
Non-synonymous genetic variation has been character-
ized in exonic regions of canine Toll-like Receptors. The
TaqMan OpenArray(R) plate developed to capture the in-
dividual variability that affects protein function will allow
high-throughput genotyping either to study association to
infection susceptibility or even TLR evolution in the canine
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Toll-like receptors (TLRs) are the most widely studied
pattern recognition receptors (PRRs) and are considered
to be the primary sensors of pathogens in innate im-
munity. These molecules are constituted by leucine-rich
repeat (LRR) domains, a unique intramembrane domain
and a Toll/Interleukin-1 receptor (TIR) domain. Pathogen-
associated molecular Patterns (PAMPs) are sensed through
LRR domain, and signals are transduced through TIR
domain, which is always located in the cytoplasm, in order
to activate innate immunity response (for a review, see [1]).
Ten TLRs have been identified in dogs. TLRs can be
classified into groups, depending on the PAMPs detected
and their cellular location. TLR 1, 2, 4, 5 and 6 detect
pathogen extracellular components. TLRs 3, 7, 8 and 9
target nucleic acids. The ligand for TLR10 is unknown [2].
Another way to classify TLRs is their cellular location.
TLRs 1, 5, 6 and 10 are expressed at the cell surface and
mainly recognize bacterial products. On the other hand,
TLRs 3, 7, 8 and 9 are located almost exclusively in
intracellular compartments and are specialized in recog-
nition of nucleic acids, with self versus non-self discrim-
ination provided by the exclusive localization of the
ligands rather than their different molecular structure
from that of the host. TLRs 2 and 4 can be located both
on the cell surface and intracellular [2,3]. In this study,
TLRs will be divided in two groups: TLRs 1, 2, 4, 5, 6
and 10 as extracellular TLRs and TLRs 3, 7, 8 and 9 as
intracellular TLRs and nucleic acid sensors.
TLRs are conserved through evolution, from Drosophila
to mammals (reviewed at [4]), because of its essential role
in innate immunity. However, there are significant distinc-
tions between intracellular and extracellular TLRs. Intra-
cellular TLRs do not accept much variability, because they
have evolved under strong purifying selection [5]. Viruses
can only be detected through their nucleic acids; therefore
intracellular TLRs have an essential non-redundant role in
host survival. Moreover, mutations in those TLRs could
end up with an autoimmune disease against own nucleic
acids or with high susceptibility to some viral infections.
On the other hand, membrane or extracellular TLRs
have evolved under less evolutionary pressure, due to they
can recognize one pathogen through different PAMPs
(immunological redundancy). So they show a higher rate
of damaging non-synonymous and STOP mutations.
Although infective pressure that has reached these
molecules is one of the main mechanisms of evolution,
it is not the only one. Non-adaptative evolution has also
an important role, through genetic drift, bottlenecks and
migratory routes [6]. This kind of evolution should be
seen in dogs, due to a first bottleneck with domestica-
tion and a second one for the artificial selection of
breeds [7]. For these reason it should be taken into
account the need for dealing with different breeds, andeven with the wolf, for the analysis of canine TLR
polymorphism.
In humans, many studies are addressed to find out pos-
sible links between some TLR polymorphism and suscep-
tibility or resistance to disease (for a review see [6]). Some
genetic variants in TLRs in dogs could be associated to
differences in breed innate immune response to pathogens
and thus to susceptibility to infections or autoimmune
diseases. So far, polymorphisms in TLR4 and TLR5 have
been associated with Inflammatory Bowel disease (IBD) in
German Shepherd dogs (GSD) [8], but only protective
SNPs from TLR5 have been associated with IBD in other
38 dog breeds [9] There is therefore great interest in the
characterization of canine TLRs. TLR5 risk-associated
haplotype for canine IBD confers hyper-responsiveness to
flagellin [10]. Moreover, dogs with spontaneous IBD ex-
hibit alterations in the enteric microbiota, which bear
resemblance to dysbiosis reported in humans with chronic
intestinal inflammation [11].
Although no other polymorphisms have been associ-
ated to illness in dogs until date, some studies have
reported differential expression of some TLRs related to
inflammatory or infectious diseases, such as TLR2 in
IBD [12], TLRs 2, 4, 5 and 9 in chronic enteropathies in
German Shepherd [13,14]; TLR4 in osteoarthritis [15]
and in infected canine endometrium [16]; TLRs 1-4, 6-
10 in sino-nasal aspergillosis and idiopathic lymphoplas-
macytic rhinitis [17]; and TLR2 and TLR9 in Leishmania
infected dogs [18,19].
So our aim is the analysis of genetic variation in exonic
regions of canine TLRs by massive sequencing, focusing in
non-synonymous substitutions and their segregation in
different dog breeds and wolf populations. A second
objective is to design and validate a TaqMan OpenArray®
plate of SNPs with a possible functional effect in the pro-
tein (STOP, frameshift and non-synonymous codons).
High-throughput genotyping of canine TLRs with this
TaqMan OpenArray® plate will allow studying the associ-
ation of non-synonymous variants with individual differ-
ences in immune response, their relationship with either
the commensal or the disease associated microbiota and
TLR evolution in the canine genome.
Results
We have identified 156 new variants in canine TLRs by
massive sequencing after the enrichment of exonic re-
gions. DNAs from 335 dogs (seven breeds) and 100 wolves
(two populations) were pooled in 16 pools and sequenced
in 2 lanes of Illumina Hiseq, with a mean coverage value
of 15,162.23. Dog breeds included were Beagle, Labrador,
German Shepherd, Yorkshire, French Bulldog, Boxer and
Shar Pei. Wolves included were Iberian (Canis lupus
signatus) and Russian (European grey wolf, Canis lupus
lupus). A total of 204 variants were detected: 193 SNP and
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indels (insertion/deletion) mapped to an exonic region
(TLR7 3′ UTR), meanwhile the others were mapping to
intronic regions (5 out of 11) and intergenic regions up-
stream or downstream a TLR gene (5 out of 11). The SNPs
identified were classified by functional annotation from
ENSEMBL [20] (effect and effect impact): 73 synonymous
variants, 64 non-synonymous variants and 67 modifier
variants which include intergenic (upstream and down-
stream a TLR gene), intronic and 3′ UTR (untranslated re-
gion) variants (see Table 1). None of the variants detected
in the pools analyzed had a high effect (STOP codon,
frameshift mutation or splicing) on the protein function.
The ratio of SNP discovery was 76.5% (in relation to
CanFam 3.1); 156 out of 204 variants identified were new:
43/64 non-synonymous variants (nsSNP), 56/73 synonym-
ous variants (synSNP) and 57/67 modifier variants.
Genetic variation differs among all TLRs. Variants de-
tected in either extracellular or intracellular canine TLRs
by massive sequencing and its classification according
their effect in the protein are shown in Table 1. TLR5 gene
presents the highest polymorphism, with 28 synonymous
changes and 23 non-synonymous changes (Additional
file 1, Table 1), although it also codifies for the longest
annotated protein (1422 aminoacids).
Table 2 shows the aminoacid (AA) change ratio, which
are AA changes caused by nsSNPs or frameshift mutations
divided by total number AA for each one of the TLRs.
The AA change ratio confirms that indeed TLR5 and
TLR4 are the most polymorphic ones. On the other hand,
TLR3 seem to be the most conserved receptor, just
presenting one AA change in 905 AA.
Non-synonymous SNPs
A more exhaustive analysis was performed for the 64
nsSNP detected through massive sequencing, because
they are expected to have a greater effect on the protein
function. First, a glimpse on allelic frequencies of theTable 1 Variants detected in canine TLRs by massive sequenc
Extracellular TLR
Effect impact SNP effect TLR1 TLR2 TLR4 TLR5
Low Syn coding 2 5 4 28
Moderate Non-syn coding 4 3 12 23
Total coding SNP (cSNP) 6 8 16 51
Modifier Downstream 1 4 0 0
Intron 0 0 6 3
Upstream 0 6 0 0
UTR 3′ 0 0 4 0
Total non coding SNP (ncSNP) 1 10 10 3
Total SNP 7 18 26 54
Variants are classified according to their effect on the protein and their spread alonnsSNP was performed. The frequencies of the alternative
allele for all 64 nsSNPs are shown for each breed and
wolf pools in Additional file 2.
Allelic frequencies for alternative variants in nsSNPs
differ among breeds. Beagle and Russian wolf are the
most variable pools, with 35 out of 64 nsSNPs segregat-
ing. Some of the variants identified are breed-specific (8
out of 64) or wolf-specific (4 out of 64). Most of the
breed specific variants are found in TLR5 and TLR4,
which as seen before, are the most polymorphic TLRs.
German Shepherd dogs (GSD) and wolf share 3 nsSNPs,
all located in TLR4. The same happens with Shar Pei
and wolf, they share 3 nsSNPs located in TLR2, TLR5
and TLR6.
SNPs with a MAF (Minor allele frequency) <0.05 have
been considered to be fixed in the cohort [21]. Usually it
is the reference allele the one which is fixed, but in some
cases (perhaps due to bad annotation of the SNP) is the
alternative one. Iberian wolves’ cohort is the one with
more fixed variants, with only 24 out of 64 that are
segregating, followed by Yorkshire and Boxer, with 25
out of 64 segregating variants.
Predicted impact of canine TLRs amino acid substitutions
Polyphen-2 [22,23], SIFT [24,25], and PROVEAN [26,27]
tools were used in order to predict the effect of each
nsSNP in the protein structure. Each of these tools uses a
different algorithm to predict the consequence of the ami-
noacid change on the protein and classifies it as benign/
tolerated/neutral or damaging/affect protein function/
deleterious (for more detail, see Methods). 28 out of 64
nsSNPs were predicted to have an effect on the protein
structure by at least one of the tools used (Table 3). When
frequency of the alternative variant was high for all the
cohorts tested, the alternative allele was exchanged with
the reference allele in ENSEMBL sequences [20] in order
to perform the Polyphen-2 analysis with the less frequent
variant as the “alternative variant”. Therefore, SNPs withing
s Intracellular TLRs
TLR6 TLR10 TLR3 TLR7 TLR8 TLR9 Total
2 5 6 6 8 7 73
4 3 1 3 4 7 64
6 8 7 9 12 14 137
2 3 0 0 2 1 12
0 0 10 7 0 2 28
2 1 1 1 1 0 12
0 0 0 10 0 0 14
4 4 11 18 3 3 66
10 12 18 27 15 17 204
g cell surface or intracellular TLRs.
Table 2 Total number of variants affecting protein in extracellular and intracellular TLRs
Canine gene ENSEMBL protein ID Protein length (aa) AA change ratioa
Extracellular TLRs
TLR1 ENSCAFP00000032660 790 1/113
TLR2 ENSCAFP00000012269 785 1/196
TLR4 ENSCAFP00000031395 833 1/69
TLR5 ENSCAFP00000016726 1422 1/53
TLR6 ENSCAFP00000023836 797 1/199
TLR10 ENSCAFP00000023840 807 1/269
Intracellular TLRs
TLR3 ENSCAFP00000011004 905 1/905
TLR7 ENSCAFP00000017193 1121 1/374
TLR8 ENSCAFP00000031505 1038 1/260
TLR9 ENSCAFP00000030804 1032 1/129
Variants from CanFam 3.1 have been added to variants identified by massive sequencing in this table. aAA change ratio: aminoacid changes caused by nsSNPs or
frameshift mutations divided by the length of the protein in aminoacids.
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tested also for the annotated reference allele. Then, 3 more
SNPs were predicted to affect the protein structure (indi-
cated as reference on the column dbSNP ID in Table 3).
When considering also these ones, 31 out of 64 nsSNPs
(48%) were predicted to have an impact on the protein
structure. Results from Polyphen-2, SIFT and PROVEAN
were convergent in predicting damaging effects for 8 out
of 31 nsSNPs (27%). On the other hand, 6 out of 64
nsSNPs were not correctly predicted, giving unknown or
low confidence results, because they were not aligning to
enough similar sequences to give a reliable result. Curi-
ously most of this nsSNPs were located on the N-terminal
region of TLR5.
Protein structure of the canine TLRs was assessed
using SMART [28,29], which predicts domains taking
into account aminoacid sequences: 6 out of 31 nsSNPs
predicted to be damaging in canine TLRs were found to
be in a Leucine Rich Repeat C-terminal (LRRCT) or
really close to it. Only 1 out of 31 was found to affect
TIR domain in TLR 5, other 2 were found to be really
close to this domain in TLR5 and 10. With the excep-
tion of these last ones, nsSNPs were in most cases
located in the sensor domain of TLRs (Table 3).
Frequencies in Table 3 are an average of all dog pools
tested and both wolf populations respectively, so all vari-
ants are polymorphic (MAF > 0.05) at least in one breed.
17 out of 31 show a MAF > 0.05 when considering the
average frequencies in all the pools together (15 out of
31 with MAF > 0.05 in wolf populations). However, as
mentioned above, frequencies of nsSNPs differ among
breeds (see Additional file 2). It’s worthy to note the
differences on the alternative allele frequency observed
for the 8 nsSNPs that were predicted to affect protein
function by the three tools used (Figure 1).TaqMan open array design and SNP validation
A TaqMan OpenArray® plate has been developed for the
validation of the nsSNPs by individual genotyping (Table 4).
This panel contains (i) 27 out of 31 nsSNPs that were pre-
dicted to have an impact on the protein structure (4 wolf-
specific SNPs were not considered for the array: TLR1
A525V, TLR5 N833K, TLR6 P579L and TLR10 F787L; see
Table 3); (ii) 28 out of the 33 remaining nsSNPs segregat-
ing in dogs (5 SNPs that were not suitable for a correct
primer design were rejected for posterior analysis: TLR4
T36A, TLR4 T36I, TLR5 T243A, TLR5 Q213R and TLR9
A442V); and (iii) 4 frameshift and 4 non-synonymous TLR
polymorphisms described on CanFam 3.1 but not detected
in our cohorts (see Table 4). One of the non-synonymous
variants added (rs23572381, TLR1 N634K) was designed
with two different TaqMan assays due to the presence of
other variants close to the interrogated SNP.
A total of 99 DNA samples of the first massive sequen-
cing pools were chosen to be individually genotyped in
order to validate the SNPs with the TaqMan Open Array®
designed: 15 Beagle, 15 Boxer, 14 French bulldog, 15
Labrador, 15 German Shepherd dog, 13 Yorkshire and 12
Shar Pei were used. One Shar-Pei and 2 Yorkshires do not
pass the quality control for samples (call rate > 0.9) and
were removed from the posterior analysis. Finally, analysis
was performed with a total of 96 individuals. Fifty-nine
out of the 64 SNPs (92%) included in the OpenArray have
been successfully validated and all of them had a call rate
greater than 0.9.
Some downstream analyses have been performed with
the individual genotypes. However, it should be taken
into account that these are just preliminary results,
which need to be validated with larger cohorts of dogs.
All the TLR SNPs were in Hardy-Weinberg Equilibrium
(HWE) on Beagle, Boxer, German Shepherd, Labrador and
Table 3 Non-synonymous SNPs predicted to impact protein function either by Polyphen-2, SIFT or PROVEAN
Canine
gene
Position SNP dbSNP ID AA
Subst
Protein
domaina
Polyphen-2
result
SIFT result Provean
result
Variant freq
(dog)b
Variant freq
(wolf)b
EXTRACELLULAR TLRs
TLR1 3:73542337 G/T rs23585044 S29I ncp Pos. damaging Tolerated Neutral 0,36 0,77
3:73543092 T/G new S281A ncp Pos. damaging Tolerated Neutral 0,06 0,00
3:73543825 C/T new A525V LRRCT2 Pos. damaging Tolerated Deleterious 0 0,11
TLR2 15:51463020 C/A rs22410121 S46Y ncp Pos. damaging Tolerated Neutral 0,10 0,00
15:51464430 C/T new S516L ncp Prob. damaging Aff. function Deleterious 0,14 0
TLR3 16:44623632 C/G new E176D ncp Pos. damaging Tolerated Neutral 0,16 0,12
TLR4 11:71356420 C/T reference1 A8V ncp Prob. damaging Tolerated Neutral 0,77 0,57
11:71360887 G/A new V82M ncp Pos. damaging Tolerated Neutral 0,09 0,15
11:71364581 T/C rs22145736 L167P ncp Prob. damaging Aff. function Deleterious 0,15 0
11:71364681 A/C reference1 Q200H ncp Pos. damaging Aff. function Neutral 0,88 0,23
11:71365810 A/G new T577A LRRCT3 Pos. damaging Aff. function Neutral 0,01 0
TLR5 38:23702837 C/T rs9070447 R269C ncp Prob. damaging Aff. function Neutral 0,19 0,01
38:23702918 G/A new V296I ncp Pos. damaging Tolerated Neutral 0,05 0,26
38:23703629 G/A new G533S ncp Prob. damaging Tolerated Neutral 0,02 0
38:23704331 G/T new D767Y ncp Prob. damaging Tolerated Deleterious 0,04 0
38:23704531 C/G new N833K LRRCT Pos. damaging Tolerated Deleterious 0 0,06
38:23704562 C/T new R844C LRRCT Pos. damaging Tolerated Neutral 0,04 0,39
38:23704581 C/T reference1 S850L LRRCT Prob. damaging Aff. function Deleterious 0,68 0,02
38:23704695 T/G new F888C low
complexity
Prob. damaging Aff. function Deleterious 0,04 0
38:23705081 C/T new H1017Y TIR Benign Aff. function Neutral 0,02 0
38:23705264 G/A new A1078T TIR4 Pos. damaging Aff. function Neutral 0,07 0,00
TLR6 3:73521250 A/G new Y182C ncp Prob. damaging Tolerated Deleterious 0,01 0,09
3:73522074 C/T new L457F ncp Prob. damaging Aff. function Deleterious 0,03 0
3:73522242 G/A rs23570247 D513N ncp Pos. damaging Tolerated Neutral 0,73 1,00
3:73522441 C/T new P579L LRRCT Pos. damaging Aff. function Deleterious 0,01 0,07
TLR10 3:73569402 C/T rs23518574 T361M ncp Prob. damaging Aff. function Deleterious 0,13 0,12
3:73570681 T/A new F787L TIR5 Pos. damaging Low
confidence
Neutral 0,00 0,39
INTRACELLULAR TLRs
TLR8 X:9397240 T/C new V157A ncp Pos. damaging Aff. function Deleterious 0,06 0
TLR9 20:37544129 G/A new V87I ncp Benign Aff. function Neutral 0,02 0
20:37546230 C/T new P787L ncp Pos. damaging Tolerated Neutral 0,22 0,24
20:37546454 C/T new R862W ncp Prob. damaging Tolerated Neutral 0,2 0
In italics, SNPs that are predicted to have an effect on protein function by the three algorithms. ancp, no confident prediction. bObserved frequency by massive
sequencing. 1reference allele tested as the alternative in the SNP. 2Leucine Rich Repeat C-terminal (LRRCT) domain predicted from aminoacid 528 to 582. 3LRRCT
domain predicted from aminoacid 579 to 629. 4TIR domain predicted from aminoacid 927 to 1074. 5TIR domain predicted from aminoacid 641 to 784.
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equilibrium which are not in HWE, one of them is predicted
to affect protein function by the algorithms tested (Table 3).
French Bulldog was the breed that had more SNPs that did
not follow HWE proportions, with 3 SNPs in TLR4 and one
SNP in TLR5 (Table 5). TLR7 and 8 were not included
because they are both located in chromosome X.Principal components analysis (PCA) combined data
from the individual genotypes obtained for the subset of
SNPs which were not in linkage disequilibrium. It was used
to illustrate if dogs cluster by breed for genetic variants in
TLRs. The first two components from the PCA have been
plotted in Figure 2. Visual examination of this plot
shows overlapping for most breeds, excluding Labrador
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Figure 1 Breed allelic frequencies for the 8 nsSNP with a damaging prediction from Polyphen-2, SIFT and PROVEAN.
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differentiated for these receptors.Discussion
Canine breed specific variants in TLRs could be associated to
differences in breed innate immune response to pathogens
and thus to susceptibility to infections or autoimmune dis-
eases. So far, polymorphisms in TLR4 and TLR5 have been
associated with IBD in German Shepherd dogs [8], but only
protective SNPs from TLR5 have been associated with IBD
in other 38 dog breeds [9]. There is therefore great interest in
the characterization of canine TLRs. Different dog breeds and
2 different populations of wolves (Iberian and Russian) were
included in the analysis to represent some of the major
phylogenetic radiations: Wolves, Ancient&Spitz breeds, Scent
hounds, Working dogs, Mastiff-like dogs, Small Terriers and
Retrievers [30]. A total of 204 variants have been discovered
and functionally annotated in exonic regions of canine TLRs
by massive sequencing: 155 of the variants were new in rela-
tion to the most recent annotation of the canine genome
(CanFam 3.1; September 2012). Variants have been function-
ally annotated and correspond to 64 non-synonymous vari-
ants (43 new), 73 synonymous variants (56 new) and 67
modifier variants (57 new). None of the variants detected in
the pools analyzed had a high effect (STOP codon, frameshift
mutation or splicing) on the protein function, although 4
frameshift mutations are annotated in CanFam 3.1.
SNPs functionally annotated as non-synonymous are
expected to have a greater effect on protein function, and
therefore a more exhaustive analysis was performed on
them. Although allelic frequencies for nsSNPs differ
among breeds and 12.5% of them are breed-specific (6.25%
are wolf specific), dogs from different breeds share most
non-synonymous variants in TLRs.A TaqMan OpenArray® plate containing 64 SNPs with a
possible functional effect in the protein (4 frameshifts and
60 nsSNPs) has been designed and validated. 55 out of 64
SNPs contained in the OpenArray® plate have been identi-
fied in this work through massive sequencing by HISEQ;
the remaining 9 were obtained from CanFam 3.1.
As shown in Figure 2, the individual genotypes are not
clustering by breed, with the exception of Labrador and
German Shepherd dogs.
The functional impact of non-synonymous variants in
dog TLRs was predicted using Polyphen-2, SIFT and PRO-
VEAN. Knowing that TLRs are highly conserved recep-
tors, it is not unexpected that half non-synonymous
mutations in dogs have a benign effect, which agrees with
results from similar approaches in other non-primate
species such as bovine [31]. In dogs, TLR5 is the one that
presents more damaging non-synonymous mutations (pos-
sibly damaging + probably damaging), followed by TLR4,
both of them extracellular receptors.
Results from SIFT and Polyphen-2 from some nsSNPs
located in TLR5 returned no output and no prediction
(“unknown” or “low confidence”). In dogs, TLR5 was de-
scribed as a longer protein compared to their homologs in
other species. In CanFam 3.1 TLR5 has 1422 aminoacids,
however other species like human, cow and pig have 858
aa, 858 aa and 856 aa, respectively. A protein BLAST was
performed with the extra 5′ and 3′ TLR5 fragments, but
no result was obtained. Furthermore, the 5′ sequence
begins with ATG codon in the same phase as the initial
coding ATG in other species, whereas the 3′ sequence
eliminates the STOP codon due to some repeats in
tandem (data not shown). So, bad annotation of this gene
in CanFam3.1 is suggested. However, SNPs have been
found in this region. In fact, there are 2 SNPs that had
already been wrongly described as an aminoacid change
Table 4 Non-synonymous SNPs and frameshift mutations of canine TLRs in the TaqMan Open Array plate
Canine gene SNP Chr:bp position dbSNP ID AA Subst Previous detecteda Validated?
TLR1 G/T 3:73542337 rs23585044 S29I Massive seq YES
T/G 3:73543092 new S281A Massive seq YES
G/A 3:73543185 new V312I Massive seq YES
T/A 3:73544153 rs23572381 N634K1 CanFam 3.1 YES2
T/A 3:73544153 rs23572381 N634K1 CanFam 3.1 NO
G/A 3:73544221 rs23572380 S657N CanFam 3.1 YES2
TLR2 C/A 15:51463020 rs22410121 S46Y Massive seq YES
A/0 15:51464076 rs8958543 A398- CanFam 3.1 YES2
C/T 15:51464430 new S516L Massive seq YES
C/T 15:51464700 new T606M Massive seq YES
TLR3 C/G 16:44623632 new E176D Massive seq YES
TLR4 T/C 11:71356420 rs22120766 V8A Massive seq NO
G/C 11:71360743 rs22157966 A34P Massive seq YES
G/A 11:71360887 new V82M Massive seq YES
T/C 11:71364581 rs22145736 L167P Massive seq YES
C/A 11:71364681 rs22189454 H200Q Massive seq YES
A/G 11:71364769 rs22189456 K230E Massive seq YES
G/A 11:71365120 new A347T Massive seq YES
A/T 11:71365652 rs22124023 E524V Massive seq YES
A/G 11:71365810 new T577A Massive seq YES
G/A 11:71365888 rs22123995 E603K Massive seq YES
TLR5 G/A 38:23702193 rs24029590 G54E CanFam 3.1 NO
0/C 38:23702251 rs9070448 -74C CanFam 3.1 YES2
A/G 38:23702514 rs9070450 Y161C CanFam 3.1 NO
A/C 38:23702539 new E169D Massive seq YES
G/A 38:23702562 new S177N Massive seq YES
G/C 38:23702640 rs9070451 R203P Massive seq YES
T/C 38:23702684 rs9070452 W218R Massive seq NO
C/T 38:23702837 rs9070447 R269C Massive seq YES
G/A 38:23702918 new V296I Massive seq YES
T/C 38:23703180 new L383S Massive seq YES
G/A 38:23703237 new R402Q Massive seq YES
G/A 38:23703279 new R416Q Massive seq YES
T/0 38:23703591 rs9125247 T520- CanFam 3.1 YES2
G/A 38:23703629 new G533S Massive seq YES
G/A 38:23704233 new R734Q Massive seq YES
G/T 38:23704331 new D767Y Massive seq YES
C/T 38:23704562 new R844C Massive seq YES
T/C 38:23704581 rs24029975 L850S Massive seq YES
T/G 38:23704695 new F888C Massive seq YES
G/A 38:23704718 new A896T Massive seq YES
C/T 38:23705081 new H1017Y Massive seq YES
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Table 4 Non-synonymous SNPs and frameshift mutations of canine TLRs in the TaqMan Open Array plate (Continued)
G/A 38:23705090 new G1020S Massive seq YES
G/A 38:23705178 new R1049Q Massive seq YES
G/A 38:23705264 new A1078T Massive seq YES
TLR6 A/G 3:73521250 new Y182C Massive seq YES
C/T 3:73522074 new L457F Massive seq YES
G/A 3:73522242 rs23570247 D513N Massive seq YES
TLR7 C/G X:9334108 new A16G Massive seq YES2
C/A X:9355727 new F167L Massive seq YES
C/T X:9358423 new P1066L Massive seq YES
TLR8 T/C X:9397240 new V157A Massive seq YES
G/A X:9397663 new R298Q Massive seq YES
G/A X:9398094 rs24607342 G442S Massive seq YES
G/A X:9398827 rs24607358 R686H Massive seq YES
TLR9 G/A 20:37544129 new V87I Massive seq YES
0/A 20:37544851 rs9188882 -328A CanFam 3.1 YES2
A/G 20:37545011 new K381E Massive seq YES
C/A 20:37545245 new P459T Massive seq YES
A/G 20:37546031 rs22882109 S721G Massive seq YES
C/T 20:37546230 new P787L Massive seq ND3
C/T 20:37546454 new R862W Massive seq YES
TLR10 C/T 3:73569402 rs23518574 T361M Massive seq YES
A/G 3:73570094 new M592V Massive seq YES
aMassive seq indicates a SNP variant detected in our cohorts. An “rs” name is indicated in dbSNP ID if the SNP is annotated in CanFam 3.1. 1SNP considered twice
with a different surrender SNP in order to detect it. 2Assay has been validated technically, although not genetically because all individuals have only the reference
allele. 3ND (not determined), there are incongruent results: massive sequencing showed that this SNP was present at a frequency of 0.2 in all breeds tested,
whereas it has not been genotyped through TaqMan OA plate.
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http://www.cgejournal.org/content/1/1/11(in ENSEMBL) moreover in this study 5 more SNPs
have been detected. So it would be interesting to either
determine the existence and functionality of these extra
fragments in canine TLR5 cDNA or correctly annotate it
in CanFam 3.1.
Intracellular TLRs, which detect nucleic acids, have
less nsSNPs (15), moreover these are predicted to be less
damaging variants than those identified in extracellular
TLRs, suggesting that intracellular TLRs are selectively
constrained. TLR9 is the intracellular TLR that acceptsTable 5 SNPs in different breeds that are not in Hardy-Weinb
Breed Canine gene AA change SNP
Yorkshire TLR10 T361M C/T
Yorkshire TLR10 M592V A/G
French B. TLR4 V82M G/A
French B. TLR4 H200Q C/A
French B. TLR4 K230E A/G
French B. TLR5 S177N G/A
agenotypes, indicate genotype count for reference homozygotes, heterozygotes an
*possibly damaging when reference allele is tested as alternative in the SNP.more nsSNPs in dogs, but the predicted effect of these
nsSNPs is usually benign.
These results agree with previously reported data reveal-
ing major differences in the intensity of selection acting
upon the different members of the TLR family. Different
TLRs differ in their immunological redundancy, reflecting
their distinct contributions to host defense [5,32]. Intracel-
lular TLRs act as nucleic acid sensors and have evolved
under strong purifying selection, indicating their essential
non-redundant role in host survival. Higher rates oferg Equilibrium (p < 0.05)
Genotypesa p-value SNP predictionb
1/1/9 0.0416978 Prob. damaging
1/1/9 0.0416978 Benign
4/2/8 0.0099493 Pos. damaging
6/1/7 0.0013535 Pos. damaging*
6/1/7 0.0013535 Benign
0/11/3 0.0154748 Benign
d alternative homozygotes. bSNP prediction, using Polyphen-2 classification.
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Figure 2 Principal Component Analysis (PCA) plot of the two first components for canine TLRs.
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tolerated in cell-surface or extracellular TLRs, which
recognize compounds other than nucleic acids, suggesting
a higher redundancy.
Location of the SNPs in the protein was approached
using the software SMART [28], which identifies TLR
domains using the aminoacid sequence. The intracellular
TIR domain is highly conserved between different TLRs
and species due to its involvement in intracellular signal-
ing [33]. Also in dogs, TIR domains have few SNPs; only
one is present in the predicted TIR domain (TLR5
H1017Y) and another two are really close to it (TLR5
A1078T and TLR10 F787L). Extracellular domains of
TLRs are those that recognize PAMPs, and they have an
enhanced susceptibility to mutate adapting to different
microbiologic environments [33]. It can also be seen that
a high number of mutations (some with damaging effects)
are located in LRR domains, which form the extracellular
domain of TLRs.
So far, polymorphisms in TLRs have been associated with
Inflammatory Bowel disease (IBD) in German Shepherd
dogs (GSD) and in other breeds. Variants in TLR5 previ-
ously reported to be associated to IBD (G22A, C100T and
T1844C from [8,9]) have been also detected in our cohorts
and correspond with TLR5 T243A, TLR5 R269C and TLR5
L850S respectively.
SNP G22A, where the risk allele is A in G22A (corre-
sponding to Thr in TLR5 T243A as named in this work),
is found to be an additive allele. So when a GSD is
homozygous for the risk allele it has more susceptibility
to suffer IBD. This risk allele is not segregating in our
GSD cohort. This could be due to the difference in the
geographical origin of the GSD cohort between both
studies. In [9] GSD are from UK, whilst our cohort is
from Spain. SNPs C100T and T1844C were found to
be significantly protective against canine IBD in manybreeds [9]. The frequencies of the protective alleles (T in
C100T and T in T1844C or Cys in TLR5 R269C and Leu
in TLR5 L850S as named in this work) differ among
breeds (Figure 3), with a frequency higher than 0.5 in
Yorkshire and GSD.Conclusions
Polymorphisms in the exonic regions of canine TLRs
have been characterized by massive sequencing and
156 out of 204 variants identified were new: 43/64
non-synonymous variants, 56/73 synonymous variants
and 57/67 modifier variants. None of the variants
detected in the pools analyzed had a high effect (STOP
codon, frameshift mutation or splicing) on the protein
function.
A TaqMan OpenArray® plate containing 64 SNPs with
a possible functional effect in the protein (4 frameshifts
and 60 nsSNPs) has been designed and validated to
allow the high throughput genotyping of canine TLRs.Methods
Ethics statement
The dogs in the study were examined during routinary
veterinary procedures by the veterinary clinics participat-
ing in the study. All samples were collected for routine
diagnostic and clinical purposes. The samples were
obtained during veterinary procedures that would have
been carried out anyway and DNA was extracted from
residual surplus of samples and used in the study with
verbal owner consent. This is a very special situation in
veterinary medicine. As the data are from client-owned
dogs that underwent normal veterinary exams, there was
no “animal experiment” according to the legal defini-
tions in Spain and the United Kingdom, and approval by
an ethical committee was not necessary.
00.1
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Figure 3 Observed allele frequency of the alleles related with IBD in our pools (A in G22A, and T in both C100T and T1844C).
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Samples available from the DNA bank at the SVGM
(Molecular Genetics Veterinary Service, UAB) were used.
Total DNA from blood cells had been extracted either as
described elsewhere [34] or using QIAamp DNA Mini Kit
(Qiagen).
DNAs from 7 different dog breeds, including 50 Beagle,
50 German Shepherd, 50 Yorkshire, 35 French bulldog, 75
Boxer, 50 Labrador and 25 Shar Pei were used. All the
dogs included in this study are from Spain region, and
come from hospital population or normal pet dogs. Also 2
different populations of wolves, with 50 Iberian (Canis
lupus signatus) and 50 Russian (European grey wolves,
Canis lupus lupus), were analyzed. DNA pools were
prepared with 200 ng of DNA from 25 unrelated dogs
(with the exception of one pool of French bulldogs, with
only 10 dogs). Two pools of each breed were analyzed, in
exception of Shar Pei (only 1 pool) and Boxer (3 pools).
Pools of wolves were of 50 individuals.
Some DNA samples of the first massive sequencing
analyses were chosen to be individually genotyped in order
to validate SNPs in the TaqMan Open Array® designed
(15 Beagle, 15 Boxer, 14 French bulldog, 15 Labrador, 15
German Shepherd, 13 Yorkshire and 12 Shar Pei).
Exon capture and massive sequencing for SNP discovery
Twenty exonic regions of 10 canine TLR genes annotated
in CanFam 2.0 were chosen to perform the enrichment
(see Additional file 3 with corresponding coordinates in
CanFam 3.1).
Oligonucleotides were first automatically designed for
the enrichment of selected regions [35]. Regions rejected
in the automated design, because of the presence of gaps,
repeats or shorter sizes than required (at least 120 nucleo-
tides) were manually redesigned. Finally 235 ultra-long
120-mer biotinylated cRNA baits were designed to capture
the exonic regions of canine TLRs (28,200 bases) by the
Agilent Sure Select technique. High-throughput sequencingwas performed using 2 lanes of Illumina HISEQ, with
8-labelled pools each, at CNAG (Centre Nacional d’Anàlisi
Genòmica, Barcelona, Spain).
Sequences obtained were mapped to CanFam 3.1 (re-
leased September 2012). All pools were analysed together
for variant calling, for better comparison. Alternative
variant frequencies were estimated for each breed pool
and wolf populations. The variants were annotated with
statistical information from the Genome Analysis Tool Kit
(GATK) and functional annotations were added from
Ensembl using snpEff [36].
Prediction of functional impact of non-synonymous SNPs
The functional impact of non-synonymous mutations
detected was predicted using Polyphen-2 [22,23], SIFT
[25,24] and PROVEAN [27,26]. When the mean frequency
of an alternative variant on the dog population analyzed
was more than 0.25, both alleles of those SNPs were
tested with algorithms mentioned before as reference
and alternative.
Polyphen-2 classifies mutations in three categories: be-
nign, possibly damaging and probably damaging. Polyphen
algorithm considers protein structure and/or sequence con-
servation information for each gene [23]. SIFT is based on
the evolutionary conservation of the amino acids within
protein families performing multiple sequencing analyses
using PSI-Blast algorithm. Highly conserved positions tend
to be intolerant to substitution, whereas those with a low
degree of conservation tolerate most substitutions. There-
fore, it classifies each non-synonymous polymorphism as
tolerated or affect protein function and provides also a
confidence measure [24]. PROVEAN introduced a region-
based “delta alignment score” which measures the impact
of an amino acid variation not only based on the amino
acid residue at the position of interest but also the quality
of sequence alignment derived from the neighborhood
flanking sequences. It classifies variants either as neutral or
deleterious [26].
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of each TLR using their aminoacid sequence [28].
TaqMan OpenArray® design
A TaqMan OpenArray® was designed for genotyping and
validating 64 SNPs with a possible functional effect in the
protein. Selected SNPs and their surrounding sequences, 60
nucleotides upstream and 60 nucleotides downstream were
introduced in Custom TaqMan® Assay Design Tool web
site [37] from Life Technologies® to validate if the sequences
were suitable for TaqMan assay design. Other SNPs in the
context sequences were indicated with an “N” before the
assays design. SNPs included are listed in Table 4.
Analysis was performed with the TaqMan Genotyper
software v.1.3 (Applied Biosystems). Further analysis of
individual genotypes was performed with SVS (version 7)
of Golden Helix Inc. SNPs or samples that do not pass call
rate >0.9 were removed for posterior analysis.
Additional files
Additional file 1: Total number of detected synonymous and
non-synonymous SNPs for each canine Toll-like receptor.
Additional file 2: Frequencies of coding variants obtained by massive
sequencing. Frequency per breed (50 individuals approximately) and mean
frequency per dog and wolf species. Frequency of the SNP is represented as
the frequency of the alternative allele.
Additional file 3: Coordinates of exonic regions of 10 canine TLR
genes as annotated in CanFam 3.1.
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